Nesvacumab
Nesvacumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Nesvacumab is under investigation in clinical trial NCT01997164 (Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)).
| Trade Name | Nesvacumab |
| Generic | Nesvacumab |
| Nesvacumab Other Names | Nesvacumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nesvacumab
